p38 MAPK Signaling in Physiology and Diseases

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Signaling".

Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 2011

Special Issue Editor


E-Mail Website
Guest Editor
Medical College of Wisconsin, Milwaukee, WI, USA
Interests: regulation of nuclear receptors in human cancer treatment
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

p38 Mitogen-activated protein kinases (p38MAPK) are a group of conserved protein kinases composed of four different genes: p38α, p38β, p38γ, and p38δ. While early studies showed that p38 MAPKs play an important role in inflammation and stress response, recent studies have shown that p38 family proteins are involved in many critical processes by a cell/tissues and isoform-specific mechanism. This Special Issue attempts to provide an update on recent developments in p38 MAPK signaling in inflammation, cardiovascular and metabolic disorders, neurodegeneration, and cancer. 

Our Special issue aims to provide a broad description of the primary biological functions of P38 MAPKs in physiology and diseases; characterize p38MAPK signaling networks and crosstalk; explore the mechanisms underlying the role of p38MAPK signaling; and explore the therapeutic opportunities and discuss the challenges associated with the regulation of p38 MAPK activity. We hope that this Special Issue will contribute to the knowledge on the common and specific roles of p38 family proteins in physiology and pathology, and thereby develop novel therapeutics for the treatment of p38 MAPK-associated diseases.     

Prof. Dr. Guan Chen
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • p38 MAPKs
  • inflammation
  • metabolism
  • neurodegeneration
  • and cancer

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

12 pages, 682 KiB  
Review
p38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease
by Xiao-Mei Qi and Guan Chen
Cells 2023, 12(13), 1674; https://0-doi-org.brum.beds.ac.uk/10.3390/cells12131674 - 21 Jun 2023
Cited by 4 | Viewed by 1625
Abstract
p38γ MAPK (also called ERK6 or SAPK3) is a family member of stress-activated MAPKs and has common and specific roles as compared to other p38 proteins in signal transduction. Recent studies showed that, in addition to inflammation, p38γ metabolic signaling is involved in [...] Read more.
p38γ MAPK (also called ERK6 or SAPK3) is a family member of stress-activated MAPKs and has common and specific roles as compared to other p38 proteins in signal transduction. Recent studies showed that, in addition to inflammation, p38γ metabolic signaling is involved in physiological exercise and in pathogenesis of cancer, diabetes, and Alzheimer’s disease, indicating its potential as a therapeutic target. p38γphosphorylates at least 19 substrates through which p38γ activity is further modified to regulate life-important cellular processes such as proliferation, differentiation, cell death, and transformation, thereby impacting biological outcomes of p38γ-driven pathogenesis. P38γ signaling is characterized by its unique reciprocal regulation with its specific phosphatase PTPH1 and by its direct binding to promoter DNAs, leading to transcriptional activation of targets including cancer-like stem cell drivers. This paper will review recent findings about p38γ inflammation and metabolic signaling in physiology and diseases. Moreover, we will discuss the progress in the development of p38γ-specific pharmacological inhibitors for therapeutic intervention in disease prevention and treatment by targeting the p38γ signaling network. Full article
(This article belongs to the Special Issue p38 MAPK Signaling in Physiology and Diseases)
Show Figures

Figure 1

Back to TopTop